Published in Physician Law Weekly, February 8th, 2006
The University of Essen is the primary trial site for the phase IIa clinical trial. The company now has the requisite approval and regulatory documentation in place to restart the phase IIa trial at this centre.
Patient enrollment and dosing are expected to commence at the University of Essen in February/March 2006. The other eight trial centers will, in turn, be initiated in the coming months....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly